相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ibuprofen and diclofenac treatments reduce proliferation of pancreatic acinar cells upon inflammatory injury and mitogenic stimulation
Marta Bombardo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Celecoxib and 2,5-dimethylcelecoxib inhibit intestinal cancer growth by suppressing the Wnt/β-catenin signaling pathway
Issei Egashira et al.
CANCER SCIENCE (2017)
Non-steroidal anti-inflammatory drug indometacin enhances endogenous remyelination
Anna Preisner et al.
ACTA NEUROPATHOLOGICA (2015)
Molecular Pathways: Aspirin andWnt Signaling-A Molecularly Targeted Approach to Cancer Prevention and Treatment
Manish K. Gala et al.
CLINICAL CANCER RESEARCH (2015)
Nonsteroidal Anti-inflammatory Drugs Diclofenac and Celecoxib Attenuates Wnt/β-Catenin/Tcf Signaling Pathway in Human Glioblastoma Cells
Gangadhara Reddy Sareddy et al.
NEUROCHEMICAL RESEARCH (2013)
Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells
Wenyan Lu et al.
CELLULAR SIGNALLING (2012)
Tolfenamic Acid Induces Apoptosis and Growth Inhibition in Head and Neck Cancer: Involvement of NAG-1 Expression
Sung Un Kang et al.
PLOS ONE (2012)
COX-2 Inhibitors and Cardiovascular Risk
Christopher P. Cannon et al.
SCIENCE (2012)
Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and survivin through suppressing specificity protein transcription factors
Riyaz Basha et al.
GYNECOLOGIC ONCOLOGY (2011)
Niclosamide Suppresses Cancer Cell Growth By Inducing Wnt Co-Receptor LRP6 Degradation and Inhibiting the Wnt/β-Catenin Pathway
Wenyan Lu et al.
PLOS ONE (2011)
Intervening in β-Catenin Signaling by Sulindac Inhibits S100A4-Dependent Colon Cancer Metastasis
Ulrike Stein et al.
NEOPLASIA (2011)
Diclofenac Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer by Modulation of VEGF Levels and Arginase Activity
Nina Mayorek et al.
PLOS ONE (2010)
NSAIDs: Old Drugs Reveal New Anticancer Targets
Gary A. Piazza et al.
PHARMACEUTICALS (2010)
Using the Golden Triangle to optimize clearance and oral absorption
Ted W. Johnson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Defining optimum lipophilicity and molecular weight ranges for drug candidates-Molecular weight dependent lower logD limits based on permeability
Michael J. Waring
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
A Novel Sulindac Derivative That Does Not Inhibit Cyclooxygenases but Potently Inhibits Colon Tumor Cell Growth and Induces Apoptosis with Antitumor Activity
Gary A. Piazza et al.
CANCER PREVENTION RESEARCH (2009)
Suppression of Wnt/β-catenin signaling inhibits prostate cancer cell proliferation
Wenyan Lu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Fenoprofen and ketoprofen amides as potential antitumor agents
Marko Marjanovic et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2007)
Mining the Wnt pathway for cancer therapeutics
Nick Barker et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
COX-2: A molecular target for colorectal cancer prevention
JR Brown et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Crystal structures of prostaglandin D2 11-ketoreductase (AKR1C3) in complex with the nonsteroidal anti-inflammatory drugs flufenamic acid and indomethacin
AL Lovering et al.
CANCER RESEARCH (2004)
Sulindac targets nuclear beta-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines
EMJ Boon et al.
BRITISH JOURNAL OF CANCER (2004)
Mefenamic acid-induced apoptosis in human liver cancer cell-lines through caspase-3 pathway
DH Woo et al.
LIFE SCIENCES (2004)
Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations
K Yang et al.
CARCINOGENESIS (2003)
Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues
MJ Thun et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
NSAIDs and gastrointestinal cancer prevention
K Jolly et al.
DRUGS (2002)
Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention
TA Chan
LANCET ONCOLOGY (2002)
The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate β-catenin/TCF-4 signaling
S Dihlmann et al.
ONCOGENE (2001)
分享论文
